Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

603193.SS

HOLDREMOVEGet insider-trade alerts

Runben Biotechnology Co., Ltd. · Consumer Defensive · China · $1.1B · Avg Vol: $8M/d

43
StockRank
Q
79
V
23
M
33
P/E (TTM)
22.9x
ROE
14.7%
D/E
0.0x
Dividend %
2.5%
AI CONVICTION THESIS

Runben Biotechnology is a high-quality consumer defensive company in China with strong brand equity in niche categories. However, it lacks any connection to our active macro themes, failing the Druckenmiller lens for asymmetric macro tailwinds.

COMPANY DESCRIPTION

Runben Biotechnology Co., Ltd. develops and manufactures personal care and insect repellent products, focusing on mild, plant-based formulations for infants and sensitive skin. The company operates a highly successful omni-channel sales model, leveraging e-commerce platforms to achieve rapid brand growth in China. Its competitive moat is built on strong brand equity in the maternal and child care niche, agile product development, and cost-effective supply chain management.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue126.1M152.1M194.1M227.5M21.7%
EPS0.070.090.110.1118.4%
Shares343.9M404.6M404.6M404.6M+17.6%
Debt1.2M0.6M0.4M0.2M-43.6%
Equity106.4M283.0M306.4M327.1M45.4%
Op CF24.3M37.2M37.9M40.5M18.5%
Inv CF1.4M-192.9M-43.7M-2.7M
Fin CF-1.4M143.3M-20.3M-26.2M
Loading...
PRICE (1Y)-23.3%
2.722.943.153.373.58May 15Jun 5Jun 26
SMA 50SMA 200
Close
$2.72
RSI (14)
15.9
52W High
$5.37
From 52W High
0.5%

SCORE BREAKDOWN

Quality
79
ROIC
16.3%77.6
ROE
14.7%69.1
GP/Assets
39.3%69.3
Op. Margin
19.4%84.4
FCF/Assets
8.0%74.7
Piotroski
657.3
Int. Cover
50.0x86.4
D/E Ratio
0.00x99.1
Current Ratio
10.98x98.8
Value
23
P/E (TTM)
22.9x30.2
EV/EBITDA
17.6x17.9
P/FCF
39.6x20.7
P/B
3.3x20.3
P/S
4.7x7.1
Div Yield
2.5%37.3
Momentum
33
52W High %
51%13.2
RS 6M
-31%39.2
SMA 50/200
0.94x34.0
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
19%62.5

FUNDAMENTALS

Market Cap
$1.1B
P/E (Forward)
Gross Margin
58.4%

SECTOR PEERS

Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of 603193.SS are excluded.

TickerCompanyMkt CapStockRankSignal
603193.SSRunben Biotechnology Co., Ltd.(you)$1.1B43HOLD
003006.SZChongqing Baiya Sanitary Products Co., Ltd.$874M44HOLD
300957.SZYunnan Botanee Bio-Technology Group Co.LTD$1.9B47HOLD
6993.HKBlue Moon Group Holdings Limited$2.2B42HOLD
605009.SSHangzhou Haoyue Personal Care Co., Ltd$712M33SELL
001328.SZDencare (Chongqing) Oral Care Co., Ltd.$636M33SELL
600315.SSShanghai Jahwa United Co., Ltd.$1.6B30SELL
002919.SZMingchen Health Co.,Ltd.$740M25SELL
6090.HKButong Group$332M41HOLD
002511.SZC&S Paper Co.,Ltd$1.2B70BUY

Peer medians: ROE 8.5% · P/E 19.5x · Gross margin 33.4%

Runben Biotechnology Co., Ltd. (603193.SS) — Stock Score Summary

Runben Biotechnology Co., Ltd. (603193.SS) has a MoatMap StockRank of 43/100 based on Quality (79/100), Value (23/100), and Momentum (33/100) factor scores. The current signal is HOLD. Runben Biotechnology is a high-quality consumer defensive company in China with strong brand equity in niche categories. However, it lacks any connection to our active macro themes, failing the Druckenmiller lens for asymmetric macro tailwinds.

Runben Biotechnology Co., Ltd. develops and manufactures personal care and insect repellent products, focusing on mild, plant-based formulations for infants and sensitive skin. The company operates a highly successful omni-channel sales model, leveraging e-commerce platforms to achieve rapid brand growth in China. Its competitive moat is built on strong brand equity in the maternal and child care niche, agile product development, and cost-effective supply chain management.

Key Financial Metrics

Price$2.72
Market Cap$1.1B
P/E (TTM)22.93
Price/Book3.26
Return on Equity14.7%
Return on Invested Capital16.3%
Debt/Equity0.05
Gross Margin58.4%
Operating Margin19.4%
Revenue Growth11.3%
Dividend Yield2.5%
Free Cash Flow$28M

Runben Biotechnology Co., Ltd. operates in the Household & Personal Products industry, part of the Consumer Defensive sector (China).

Frequently Asked Questions

What is Runben Biotechnology Co., Ltd.’s (603193.SS) StockRank?
MoatMap’s StockRank for Runben Biotechnology Co., Ltd. (603193.SS) is 43/100, with a Hold signal. It is a composite of Quality (79), Value (23), and Momentum (33) factor ranks across MoatMap’s 20,000+ stock universe.
Does Runben Biotechnology Co., Ltd. have an economic moat?
Runben Biotechnology Co., Ltd. (603193.SS) has a Quality factor score of 79/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Runben Biotechnology Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Runben Biotechnology Co., Ltd. (603193.SS) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Runben Biotechnology Co., Ltd. in?
Runben Biotechnology Co., Ltd. (603193.SS) operates in the Consumer Defensive sector, specifically the Household & Personal Products industry (China).